Viewpoints

Myth: Oncology Patients Demand Inappropriate Interventions

Myth: Oncology Patients Demand Inappropriate Interventions

According to a JAMA study, only 8.7% of patients with cancer requested medical interventions and only 11.4% of those were deemed inappropriate.

Study Shows Inappropriate Medication Use Among Older Patients with Cancer

Study Shows Inappropriate Medication Use Among Older Patients with Cancer

A pharmacist-led medication assessment demonstrated a high prevalence of polypharmacy and potentially inappropriate medication use in seniors.

Feature Articles

Improved Progression-Free Survival, Response Rate with Lenvatinib in I-131

Improved Progression-Free Survival, Response Rate with Lenvatinib in I-131

Lenvatinib improved progression-free survival and response rate in I-131-refractory thyroid cancer.

Endocrine Cancer Resources

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs